Isolated one-sided cerebellar agenesis following an attempted medical termination of pregnancy

Journal of Obstetrics and Gynaecology

Volumn 26, Issue 6, 2006, Pages 581-582

  Afadapa, F K ^a   Elsapagh, K ^b  

^a Countess of Chester Hospital ^*  (United Kingdom)

^b NINEWELLS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GEMEPROST; MIFEPRISTONE;

ADULT; AGENESIS; ARTICLE; CASE REPORT; CEREBELLAR AGENESIS; CLINICAL FEATURE; FEMALE; FETUS; FETUS MALFORMATION; GESTATION PERIOD; HUMAN; PATIENT COUNSELING; PREGNANCY TERMINATION; PRIORITY JOURNAL; ULTRASOUND;

ABNORMALITIES, DRUG-INDUCED; ABORTION, INDUCED; ADULT; CEREBELLUM; FEMALE; HUMANS; MIFEPRISTONE; PREGNANCY; ULTRASONOGRAPHY, PRENATAL;

EID: 33749011958     PISSN: 01443615     EISSN: 13646893     Source Type: Journal    
DOI: 10.1080/01443610600830946     Document Type: Article

References (14)

1. Coelho KE, Sarmento MF, Veiga CM et al. 2000. Misoprostol embryotoxocity: clinical evaluation of fifteen patients with arthrogryposis. American Journal of Medical Genetics 95:297-301.
2. Genest DR, Richardson A. 1994. Limb defects and omphalocoele in a 17 week foetus following first trimester misoprostol exposure. Teratology 49:418.
3. Gonzalez CH, Vargas FR, Perez ABA et al. 1993. Limb deficiency with or without Mobius sequence in seven Brazilian children associated with misoprostol use in the first trimester of pregnancy. American Journal of Medical Genetics 47:59-64.
4. Gonzalez HC, Marques-Dias MJ, Kim Chong A et al. 1998. Congenital malformation in Brazilian children associated with misoprostol misuse in the first trimester of pregnancy. Lancet 351:1624-1627.
5. Hofmeyr GJ, Milos D, Nikodem VC et al. 1998. Limb reduction anomaly after failed misoprostol abortion. South African Medical Journal 88:566-567.
6. Hunter A, Porter H, Kyle P. 2002. Not assuming the obvious: failed medical termination of pregnancy and multiple foetal abnormalities. British Journal of Obstetrics and Gynaecology 109:1069-1071.
7. National organisation of rare diseases. 2002. Available at: http://www.rarediseases.org/search/rdblist.html
8. Orioli IM, Castilla FE. 2000. Epidemiological assessment of misoprostol teratogenicity. British Journal of Obstetrics and Gynaecology 107:519-523.
9. Pastuzak AL, Schuler L, Speck-Martins LE et al. 1998. Use of misoprostol cluting pregnancy and Mobius syndrome in infants. New England Journal of Medicine 388:1881-1885.
10. Peyron R, Aubeny E, Targosz V et al. 1993. Early termination of pregnancy with mifepristone (RU486) and the orally active prostaglandin misoprostol. New England Journal of Medicine 328:1509-1513.
11. Ricardi VM, Marcus ES. 1978. Congenital hydrocephalus and cerebellar agenesis. Clinical genetics (Copenhagen) 13:443-447.
12. Sitruk-Ware R, Davey A, Sakiz E. 1998. Foetal malformation and failed medical termination of pregnancy. Lancet 352:323.
13. Timman D, Dimitrova A, Hein-Kropp C et al. Cerebellar agenesis: Clinical and Neurophysiological and MR findings. Neurocases 9:402-413.
14. Urquhart DR, Templeton AA, Shinewi F et al. 1997. The efficacy and tolerance of mifepristone and prostaglandin in termination of pregnancy of less than 63 days gestation; UK Multicentre Study - final results. Contraception 55:1-5.